Fujirebio

News

The FDA has approved the first blood test for Alzheimer's disease based on a blood test – from Fujirebio – in a step forward for early diagnosis.

News

The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.